Abbott Launches Amplatzer Talisman System in Europe

The new Talisman PFO occluders come pre-attached to the delivery cable.

Amplatzer Talisman Pfo Occluder Trial
Abbott

Abbott today announced the European launch of its Amplatzer Talisman PFO Occlusion System to treat people with a patent foramen ovale (PFO) – a hole in the heart that doesn't close following birth – who have experienced a stroke and are at risk of having another.

The new Talisman PFO occluders come pre-attached to the delivery cable, designed to reduce preparation time for doctors and making the system easier to use.  

The Amplatzer Talisman system builds off the company's Amplatzer PFO Occluder. While physicians had to attach the Amplatzer PFO Occluder to the delivery cable before performing the implant procedure, the Talisman occluder now comes pre-assembled to the Amplatzer Trevisio™ delivery cable, reducing prep time ahead of the procedure and making it easier to use. The Talisman system accommodates a wide range of patient anatomies and an updated 30mm occluder size optimizes how it fits in the heart. The Talisman device is fully recapturable and repositionable so doctors can easily make adjustments for accurate placement.

More in Cardiovascular